McPherson's (ASX:MCP) said its McPherson's Consumer Products subsidiary entered into a pharmacy wholesaler agreement with Symbion for a three-year term starting on June 1, according to a Thursday Australian bourse filing.
Under the group's new operating model announced on Feb. 24, the current annual revenue of about AU$10 million to AU$15 million from retailers, previously serviced through the direct-to-store model, will now be serviced through its wholesale relationship with Symbion.
The company's shares were up nearly 1% in recent Thursday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.